NEW DELHI: Bharat Biotech International Ltd plans to launch its covid-19 vaccine, Covaxin, by June next year, unless the government decides to grant the vaccine an emergency use authorization before then, based on data from earlier phases of clinical trials. CEO Sai Prasad told Mint. “If the government has the …
Read More »
India’s first coronavirus disease (Covid-19) candidate vaccine, Covaxin, which is being developed by Bharat Biotech, is likely to be at least 60% effective. On Thursday evening, the company received approval from the Controller General of Medicines of India (DCGI) to conduct a phase 3 clinical trial to establish the efficacy …
Read More »
Covaxin, a candidate vaccine developed indigenously by Bharat Biotech, obtained authorization for the phase three trial in India. A leading source said that rehearsals will begin in the first week of November. The source further said that 18-19 sites have been selected for the trial and more than 22,000 volunteers …
Read More »
Bharat Biotech had said it plans to cover 28,500 subjects in its phase 3 trial. New Delhi: Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR), has been approved for the third phase of clinical trials. The Hyderabad-based vaccine maker …
Read More »
While there are three coronavirus disease (Covid-19) vaccine candidates being tested in humans in India, there are currently no intranasal vaccine candidates on trial, Union Health Minister Harsh said on Sunday. Vardhan. However, he also said that the Serum Institute of India was manufacturing an intranasal vaccine candidate. “The Flumist …
Read More »
NEW DELHI: The Serum Institute of India and Bharat Biotech are expected to conduct advanced stage clinical trials of intranasal Covid-19 vaccines in the coming months once they receive regulatory approval, Union Health Minister Harsh said on Sunday Vardhan. Vardhan said the late-stage trial typically involves thousands of participants, sometimes …
Read More »
NEW DELHI: Results from phase three trials of the Oxford-AstraZeneca vaccine underway in India could be available in “late November-early December”, raising hopes that the leading candidate anti-Covid, made in India by the Serum Institute – may be available sooner than expected. The government’s vision of a possible timeline came …
Read More »
Union Health Minister Harsh Vardhan reported Sunday that coronavirus vaccines are currently in various phases of testing. and its results are awaited. The Union Health Minister was interacting with his social media followers on the fifth episode of the ‘Sunday Samvaad’ platform. Vardhan explained that phase 1 trials for vaccines …
Read More »
File photo of Union Health Minister Harsh Vardhan. (Photo: PTI) Will it be more difficult to acquire and inoculate large swaths of the population with multiple doses, or would a single-dose vaccination plan have been easier? Yes, experts say. CNN-News18 Last update: October 11, 2020 9:49 PM IST FOLLOW US: …
Read More »
The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from vaccines that fight the virus at its point of attack – the nose and mouth. Most vaccines in human trials require two injections …
Read More »